Fund Holdings — REGENERON PHARMACEUTICALS, INC.

Total Portfolio Value:
$1.23B
Total Bought:
$0
Total Sold:
$0
Net Transaction:
$0
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Alnylam Pharmaceuticals, Inc.(ALNY)4,444,4454,444,4450$1.05B$1.20B97.23%+$154.27M
Intellia Therapeutics, Inc.(NTLA)3,702,9953,702,9950$43.18M$26.33M2.13%-$16.85M
2seventy Bio, Inc.1,254,8271,254,8270$3.69M$6.20M0.50%+$2.51M
Adverum Biotechnologies, Inc.180,909180,9090$844.8K$790.6K0.06%-$54.3K
Adicet Bio, Inc.968,183968,1830$931.4K$731.0K0.06%-$200.4K
Bluebird Bio, Inc.21,00021,0000$175.1K$102.5K0.01%-$72.7K
Page 1 of 1
REGENERON PHARMACEUTICALS, INC. — 13F Holdings — Q1 2025 | TickerTrail